Home › Compare › GIVSY vs ABBV
GIVSY yields 3.25% · ABBV yields 3.06%● Live data
📍 GIVSY pulled ahead of the other in Year 2
Combined, GIVSY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GIVSY + ABBV for your $10,000?
Grupo de Inversiones Suramericana S.A. operates in the financial services, industry, and corporate venture sectors in Colombia and internationally. The company offers general and life insurance, as well as reinsurance; pension, saving, investment, and asset management services; investment funds; annuities; severance pay and complementary services; health plans; occupational hazards; and business, consumer, insurance, investment, offshore, private, and government banking, as well as treasury products. It also produces cement, concrete, and aggregates; provides processed foods, such as cold cuts, confectionery, chocolates, coffees, ice cream, pasta, and consumer foods; and offers power generation and distribution, real estate, road and airport concessions, and business support services. In addition, the company provides a technological solution to manage human talent information for companies; a digital marketplace for mortgage sector; a platform for engagement, marketing, sale, and administration of financial products; a health technology platform; tools to manage prevention and wellbeing programs; web and mobile platform based on artificial intelligence; platform for on-demand insurance; and risk capital fund for early-stage and growing technology companies. Further, it offers integrated information, technology, and knowledge solutions; and residential, functional conditioning, and rehabilitation services for the elderly. Additionally, the company provides data processing and leasing computer equipment, consultancy and advisory, promotion, and marketing services; management consultancy services; medical, paramedical, dental, and diagnostic aid services; risk management, telecommunication, and outsourcing services; and vehicle inspection, repair, purchase, and selling services, as well as acts as securities brokers; and purchases and sells securities. The company was incorporated in 1997 and is headquartered in Medellin, Colombia.
Full GIVSY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.